Accendra Health (NYSE:ACH) Given New $4.50 Price Target at Citigroup

Accendra Health (NYSE:ACH) had its target price trimmed by Citigroup from $5.00 to $4.50 in a research note released on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other research analysts have also recently commented on the company. UBS Group increased their target price on Accendra Health from $3.00 to $4.50 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Zacks Research raised Accendra Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 21st. Weiss Ratings upgraded Accendra Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. Finally, Robert W. Baird increased their price objective on Accendra Health from $5.00 to $6.00 and gave the company an “outperform” rating in a research report on Tuesday, May 12th. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Accendra Health currently has a consensus rating of “Hold” and an average target price of $5.00.

Accendra Health Price Performance

NYSE:ACH opened at $3.13 on Friday. Accendra Health has a 52-week low of $1.84 and a 52-week high of $7.99. The company’s fifty day simple moving average is $3.12. The company has a market capitalization of $239.70 million, a price-to-earnings ratio of -0.22, a price-to-earnings-growth ratio of 4.82 and a beta of 1.58.

Accendra Health (NYSE:ACH) last announced its earnings results on Monday, May 11th. The company reported ($0.04) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.02. The business had revenue of $627.78 million for the quarter. Accendra Health had a negative return on equity of 13.18% and a negative net margin of 39.84%. On average, equities analysts predict that Accendra Health will post 0.31 earnings per share for the current year.

Hedge Funds Weigh In On Accendra Health

A number of hedge funds have recently bought and sold shares of the company. Strs Ohio purchased a new stake in Accendra Health during the 1st quarter valued at $413,000. Sei Investments Co. bought a new position in shares of Accendra Health during the 1st quarter valued at $123,000. Renaissance Technologies LLC purchased a new position in shares of Accendra Health in the 1st quarter worth $725,000. Bank of New York Mellon Corp bought a new stake in shares of Accendra Health in the first quarter worth $592,000. Finally, Dimensional Fund Advisors LP bought a new stake in shares of Accendra Health in the first quarter worth $5,943,000.

About Accendra Health

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.